The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,137,581 in first-year total cost, median $3,568,791.
Most frequent study sections
- Special Emphasis Panel[ZAI1 JBS-A (M1)]2
Most frequent institutions
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Sustained Long Acting Prevention Against HIV Program Operation1UM1AI120184-01 | HOPE, THOMASKISER, PATRICK FRANKLIN | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $3,609,469 | ZAI1 |
| 2015 | Targeted Long-acting Combination Antiretroviral Therapy (TLC-ART)1UM1AI120176-01 | COLLIER, ANN CORNWALLHO, RODNEY J.Y. | UNIVERSITY OF WASHINGTON, WA | $3,528,112 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.